ArticleMolecular medicine (Cambridge, Mass.)2012

Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells.

David M Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.